207 related articles for article (PubMed ID: 23578092)
1. Interaction of Mycobacterium tuberculosis cell wall components with the human natural killer cell receptors NKp44 and Toll-like receptor 2.
Esin S; Counoupas C; Aulicino A; Brancatisano FL; Maisetta G; Bottai D; Di Luca M; Florio W; Campa M; Batoni G
Scand J Immunol; 2013 Jun; 77(6):460-9. PubMed ID: 23578092
[TBL] [Abstract][Full Text] [Related]
2. Mycobacterium tuberculosis-induced gamma interferon production by natural killer cells requires cross talk with antigen-presenting cells involving Toll-like receptors 2 and 4 and the mannose receptor in tuberculous pleurisy.
Schierloh P; Yokobori N; Alemán M; Landoni V; Geffner L; Musella RM; Castagnino J; Baldini M; Abbate E; de la Barrera SS; Sasiain MC
Infect Immun; 2007 Nov; 75(11):5325-37. PubMed ID: 17709420
[TBL] [Abstract][Full Text] [Related]
3. Human NK cells directly recognize Mycobacterium bovis via TLR2 and acquire the ability to kill monocyte-derived DC.
Marcenaro E; Ferranti B; Falco M; Moretta L; Moretta A
Int Immunol; 2008 Sep; 20(9):1155-67. PubMed ID: 18596023
[TBL] [Abstract][Full Text] [Related]
4. Imbalance of NKp44(+)NKp46(-) and NKp44(-)NKp46(+) natural killer cells in the intestinal mucosa of patients with Crohn's disease.
Takayama T; Kamada N; Chinen H; Okamoto S; Kitazume MT; Chang J; Matuzaki Y; Suzuki S; Sugita A; Koganei K; Hisamatsu T; Kanai T; Hibi T
Gastroenterology; 2010 Sep; 139(3):882-92, 892.e1-3. PubMed ID: 20638936
[TBL] [Abstract][Full Text] [Related]
5. [Bacillus Calmette-Guérin enhances the function of human nature killer cells by inducing IL-12 production and IL-12R expression].
Zhou H; Fan YY; Wu CY
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Nov; 25(11):976-9. PubMed ID: 19900360
[TBL] [Abstract][Full Text] [Related]
6. Direct binding of human NK cell natural cytotoxicity receptor NKp44 to the surfaces of mycobacteria and other bacteria.
Esin S; Batoni G; Counoupas C; Stringaro A; Brancatisano FL; Colone M; Maisetta G; Florio W; Arancia G; Campa M
Infect Immun; 2008 Apr; 76(4):1719-27. PubMed ID: 18212080
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of direct and indirect TLR-mediated activation of human NK cells by low molecular weight dextran sulfate.
Millard AL; Spirig R; Mueller NJ; Seebach JD; Rieben R
Mol Immunol; 2010 Aug; 47(14):2349-58. PubMed ID: 20541808
[TBL] [Abstract][Full Text] [Related]
8. Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis.
Means TK; Wang S; Lien E; Yoshimura A; Golenbock DT; Fenton MJ
J Immunol; 1999 Oct; 163(7):3920-7. PubMed ID: 10490993
[TBL] [Abstract][Full Text] [Related]
9. Human tumor-induced and naturally occurring Treg cells differentially affect NK cells activated by either IL-2 or target cells.
Bergmann C; Wild CA; Narwan M; Lotfi R; Lang S; Brandau S
Eur J Immunol; 2011 Dec; 41(12):3564-73. PubMed ID: 21905023
[TBL] [Abstract][Full Text] [Related]
10. Constitutive expression of ligand for natural killer cell NKp44 receptor (NKp44L) by normal human articular chondrocytes.
Białoszewska A; Baychelier F; Niderla-Bielińska J; Czop A; Debré P; Vieillard V; Kieda C; Malejczyk J
Cell Immunol; 2013; 285(1-2):6-9. PubMed ID: 24044960
[TBL] [Abstract][Full Text] [Related]
11. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K
Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654
[TBL] [Abstract][Full Text] [Related]
12. Functional characterization of human natural killer cells responding to Mycobacterium bovis bacille Calmette-Guérin.
Esin S; Batoni G; Pardini M; Favilli F; Bottai D; Maisetta G; Florio W; Vanacore R; Wigzell H; Campa M
Immunology; 2004 May; 112(1):143-52. PubMed ID: 15096193
[TBL] [Abstract][Full Text] [Related]
13. Regulatory role of NKp44, NKp46, DNAM-1 and NKG2D receptors in the interaction between NK cells and trophoblast cells. Evidence for divergent functional profiles of decidual versus peripheral NK cells.
Vacca P; Cantoni C; Prato C; Fulcheri E; Moretta A; Moretta L; Mingari MC
Int Immunol; 2008 Nov; 20(11):1395-405. PubMed ID: 18815119
[TBL] [Abstract][Full Text] [Related]
14. Distinct indirect pathways govern human NK-cell activation by TLR-7 and TLR-8 agonists.
Gorski KS; Waller EL; Bjornton-Severson J; Hanten JA; Riter CL; Kieper WC; Gorden KB; Miller JS; Vasilakos JP; Tomai MA; Alkan SS
Int Immunol; 2006 Jul; 18(7):1115-26. PubMed ID: 16728430
[TBL] [Abstract][Full Text] [Related]
15. NKp44 triggers NK cell activation through DAP12 association that is not influenced by a putative cytoplasmic inhibitory sequence.
Campbell KS; Yusa S; Kikuchi-Maki A; Catina TL
J Immunol; 2004 Jan; 172(2):899-906. PubMed ID: 14707061
[TBL] [Abstract][Full Text] [Related]
16. Human CD56bright and CD56dim natural killer cell subsets respond differentially to direct stimulation with Mycobacterium bovis bacillus Calmette-Guérin.
Batoni G; Esin S; Favilli F; Pardini M; Bottai D; Maisetta G; Florio W; Campa M
Scand J Immunol; 2005 Dec; 62(6):498-506. PubMed ID: 16316416
[TBL] [Abstract][Full Text] [Related]
17. The direct effects of Toll-like receptor ligands on human NK cell cytokine production and cytotoxicity.
Lauzon NM; Mian F; MacKenzie R; Ashkar AA
Cell Immunol; 2006 Jun; 241(2):102-12. PubMed ID: 17049504
[TBL] [Abstract][Full Text] [Related]
18. Oligodeoxynucleotides containing palindrome sequences with internal 5'-CpG-3' act directly on human NK and activated T cells to induce IFN-gamma production in vitro.
Iho S; Yamamoto T; Takahashi T; Yamamoto S
J Immunol; 1999 Oct; 163(7):3642-52. PubMed ID: 10490958
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the recognition of tumor cells by the natural cytotoxicity receptor, NKp44.
Hershkovitz O; Jivov S; Bloushtain N; Zilka A; Landau G; Bar-Ilan A; Lichtenstein RG; Campbell KS; van Kuppevelt TH; Porgador A
Biochemistry; 2007 Jun; 46(25):7426-36. PubMed ID: 17536787
[TBL] [Abstract][Full Text] [Related]
20. Expression and function of CD7 molecule on human natural killer cells.
Rabinowich H; Pricop L; Herberman RB; Whiteside TL
J Immunol; 1994 Jan; 152(2):517-26. PubMed ID: 7506726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
